Cargando…

Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020

This cross-sectional study examines trends in drug spending in Medicare Parts B and D and describes the share of total use and spending attributed to oncology drugs within each program.

Detalles Bibliográficos
Autores principales:	Kyle, Michael Anne, Dusetzina, Stacie B., Keating, Nancy L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280395/ https://www.ncbi.nlm.nih.gov/pubmed/35816318 http://dx.doi.org/10.1001/jamanetworkopen.2022.21468

Ejemplares similares

Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
por: Dusetzina, Stacie B., et al.
Publicado: (2021)

Trends in Medicare Spending on Oral Drugs for Chronic Lymphocytic Leukemia From 2014 to 2020
por: Cliff, Edward R. Scheffer, et al.
Publicado: (2023)

Out-of-Pocket Spending Not Associated with Oral Oncolytic Survival Benefit
por: Rotenstein, Lisa S., et al.
Publicado: (2018)

Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval
por: Sachs, Rachel E., et al.
Publicado: (2021)

Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019
por: Erath, Alexandra, et al.
Publicado: (2020)

Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products
por: Gupta, Arjun, et al.
Publicado: (2022)

Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020
por: Essa, Mohammed, et al.
Publicado: (2023)

Medicare Spending on Drugs With Accelerated Approval, 2015-2019
por: Rome, Benjamin N., et al.
Publicado: (2021)

Trends in Use of and Medicare Spending on Short-Course Radiotherapy for Lymphomas From 2015 to 2019
por: Tringale, Kathryn R., et al.
Publicado: (2022)

Beneficiary Switching Between Traditional Medicare and Medicare Advantage Between 2016 and 2020
por: Unuigbe, Aig, et al.
Publicado: (2022)

Spending on and Use of Clinician-Administered Drugs in Medicare
por: Hyland, Megan F., et al.
Publicado: (2023)

Estimated Annual Spending on Aducanumab in the US Medicare Program
por: Mafi, John N., et al.
Publicado: (2022)

Prescription Drug Coverage and Spending for Medicare Beneficiaries
por: Poisal, John A., et al.
Publicado: (1999)

Outpatient prescription drug spending by the Medicare population
por: Waldo, Daniel R.
Publicado: (1987)

Changes in Medicare Part B Spending for Biologic Drugs After Biosimilar Entry Into the Market
por: Dean, Emma Boswell, et al.
Publicado: (2021)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

National Trends in Use of and Spending on Oral Anticoagulants Among US Medicare Beneficiaries From 2011 to 2019
por: Troy, Aaron, et al.
Publicado: (2021)

Trends in and Factors Contributing to the Slowdown in Medicare Spending Growth, 2007-2018
por: Buntin, Melinda B., et al.
Publicado: (2022)

Analysis of Prescriptions Dispensed After Death and Associated Medicare Spending Following Reimbursement Policy Changes in Medicare
por: Vouri, Scott M., et al.
Publicado: (2023)

Evaluation of Spending Differences Between Beneficiaries in Medicare Advantage and the Medicare Shared Savings Program
por: Parikh, Ravi B., et al.
Publicado: (2022)

Association of Out-of-Pocket Spending With Insulin Adherence in Medicare Part D
por: Trish, Erin, et al.
Publicado: (2021)

Drug Coverage, Utilization, and Spending by Medicare Beneficiaries with Heart Disease
por: Sharma, Ravi, et al.
Publicado: (2003)

State-Level Variation in Medicare Spending
por: Gage, Barbara, et al.
Publicado: (1999)

Sources of Low-Value Care Received by Medicare Beneficiaries and Associated Spending Within US Health Systems
por: Chant, Emma D., et al.
Publicado: (2023)

Medicare reimbursement trends from 2000 to 2020 in head and neck surgical oncology
por: Quereshy, Humzah A., et al.
Publicado: (2022)

Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012
por: Hernandez, Inmaculada, et al.
Publicado: (2017)

Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma
por: Jazowski, Shelley A., et al.
Publicado: (2022)

Changes in Out-of-Pocket Spending and Catastrophic Health Care Expenditures Associated With Medicare Eligibility
por: Scott, John W., et al.
Publicado: (2021)

Trends in and Factors Associated With Out-of-Pocket Spending for COVID-19 Hospitalizations From March 2020 to March 2021
por: Chua, Kao-Ping, et al.
Publicado: (2022)

Trends in medicare spending across strata of resource utilization among older individuals in the United States
por: Wallis, Christopher J.D., et al.
Publicado: (2021)

The impact of weight loss among seniors on Medicare spending
por: Thorpe, Kenneth E, et al.
Publicado: (2013)

Medicare physicians' services: The composition of spending and assignment rates
por: Burney, Ira, et al.
Publicado: (1985)

Out-of-Pocket Spending for Influenza Hospitalizations in Medicare Advantage
por: Chua, Kao-Ping, et al.
Publicado: (2021)

Trends in orphan drug use and spending among children and adolescents during 2010–2020 in Korea
por: Oh, Jung Yeon, et al.
Publicado: (2022)

Changes in Medicare Accountable Care Organization Spending, Utilization, and Quality Performance 2 Years Into the COVID-19 Pandemic
por: Yan, Brandon W., et al.
Publicado: (2023)

Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022)

DataView: Medicare Spending by State: The Border-Crossing Adjustment
por: Basu, Joy, et al.
Publicado: (1995)

Association of Medicare Spending With Subspecialty Consultation for Elderly Hospitalized Adults
por: Ryskina, Kira L., et al.
Publicado: (2019)

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
por: DiStefano, Michael J., et al.
Publicado: (2023)

Trends in Low-Value Health Service Use and Spending in the US Medicare Fee-for-Service Program, 2014-2018
por: Mafi, John N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_10tsegqm1ph7tlq0bsfle71pid